Qube Research & Technologies LTD Maxcyte, Inc. Transaction History

Qube Research & Technologies LTD

  • $65.7 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024
BUY
$3.94 - $5.38 $46,058 - $62,892
11,690 Added 200.0%
17,535 $73,000
Q4 2023

Feb 13, 2024
SELL
$2.6 - $5.24 $65,171 - $131,345
-25,066 Reduced 81.09%
5,845 $27,000
Q3 2023

Nov 13, 2023
BUY
$3.02 - $5.1 $93,351 - $157,646
30,911 New
30,911 $96,000
Q2 2022

Aug 15, 2022
SELL
$3.59 - $6.81 $68,637 - $130,200
-19,119 Reduced 47.74%
20,930 $99,000
Q1 2022

May 09, 2022
BUY
$5.26 - $10.84 $210,657 - $434,131
40,049 New
40,049 $280,000

Others Institutions Holding MXCT

# of Institutions
124
Shares Held
65.6M
Call Options Held
1K
Put Options Held
2K
View Full List

About MAXCYTE, INC.

MXCT Quotes by TradingView
  • Ticker MXCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 101,724,000
  • Market Cap $329M
  • Description
  • MaxCyte, Inc., a global life sciences company, engages in the discovery, development, and commercialization of next-generation cell therapies. Its products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expr...
More about MXCT
Track This Portfolio

Track Qube Research & Technologies LTD Portfolio

Follow Qube Research & Technologies LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

News

Stay updated on Qube Research & Technologies LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email